Search the web
Welcome, Guest
[Sign Out, My Account]
EDGAR_Online

Quotes & Info
Enter Symbol(s):
e.g. YHOO, ^DJI
Symbol Lookup | Financial Search
VRML > SEC Filings for VRML > Form 8-K on 16-Sep-2013All Recent SEC Filings

Show all filings for VERMILLION, INC.

Form 8-K for VERMILLION, INC.


16-Sep-2013

Change in Directors or Principal Officers, Financial Statements and Exhibits


Item 5.02 Departure of Directors or Certain Officers; Election of Directors;
Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.

Election of Director

On September 12, 2013, the Board of Directors (the "Board") of Vermillion, Inc. (the "Company") elected Eric Varma, MD as a Class III director, filling a vacant seat on the Board.

Dr. Varma is currently a Partner at Oracle Investment Management ("Oracle"), which is a fundamental research driven investment management company that is exclusively focused on the global health care and bioscience industries. Prior to joining Oracle, Dr. Varma worked at Leerink Swann, the Boston Consulting Group, and the Food and Drug Administration. Dr. Varma received his B.A. from the University of California Berkeley, M.D. from the Albert Einstein College of Medicine, and M.B.A. from the MIT Sloan School of Management.

Dr. Varma was designated by Oracle's affiliated funds Oracle Partners, LP and Oracle Ten Fund Master, LP, which are stockholders of the Company and collectively have the right to designate an individual to be nominated to the Board pursuant to the Stockholders Agreement dated May 13, 2013 by and among the Company and certain purchasers of the Company's common stock and warrants (the "Stockholders Agreement"). The Stockholders Agreement was filed as Exhibit 10.2 to the Company's Current Report on Form 8-K that was filed with the Securities and Exchange Commission on May 14, 2013.

On September 16, 2013, the Company issued a press release to announce Dr. Varma's election. A copy of the press release is attached hereto as Exhibit 99.1 and is incorporated herein by reference.




Item 9.01 Financial Statements and Exhibits.

(d) Exhibit No.Description.

99.1 Press Release dated September 16, 2013


  Add VRML to Portfolio     Set Alert         Email to a Friend  
Get SEC Filings for Another Symbol: Symbol Lookup
Quotes & Info for VRML - All Recent SEC Filings
Copyright © 2014 Yahoo! Inc. All rights reserved. Privacy Policy - Terms of Service
SEC Filing data and information provided by EDGAR Online, Inc. (1-800-416-6651). All information provided "as is" for informational purposes only, not intended for trading purposes or advice. Neither Yahoo! nor any of independent providers is liable for any informational errors, incompleteness, or delays, or for any actions taken in reliance on information contained herein. By accessing the Yahoo! site, you agree not to redistribute the information found therein.